Novartis introduces inflammatory villain in its first Xiidra dry eye DTC campaign beth.bulik Wed, 07/22/2020 – 13:32

Pfizer, BioNTech’s U.S. supply deal price tag leaves room for ‘decent’ profit on COVID-19 shot: analyst kblankenship Thu, […]

A research group has developed a new, lightweight and motor-less device that can be easily attached to an […]

The camera-like imaging device can be inserted into blood vessels to provide high quality 3D images to help […]

The government’s plans for tackling obesity must be part of a wider strategy to reduce health inequalities that […]

David Pencheon, founding director of the Sustainable Development Unit (SDU) for NHS England and Public Health England, is […]

Using a single dose of prophylactic antibiotic after assisted vaginal birth would prevent thousands of infections and cut […]

The letter of intent should secure access to the combination for people with cystic fibrosis upon its regulatory […]

Findings “paint a grim picture” for this winter, the researchers warn

Development of elafibranor will be discontinued for NASH, with the company now focusing on its future as a […]